Xenon Pharmaceuticals
XENE
XENE
39 hedge funds and large institutions have $31.3M invested in Xenon Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.9% less ownership
Funds ownership: 56.17% → 55.27% (-0.9%)
22% less capital invested
Capital invested by funds: $40.3M → $31.3M (-$8.97M)
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.79M | |
| 2 | +$394K | |
| 3 | +$256K | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$150K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$120K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$1.36M | |
| 3 | -$600K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$315K |
| 5 |
Renaissance Technologies
New York
|
-$273K |